EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat

Bruno Hay Mele iD, Federica Rossetti, Maria Vittoria Cubellis iD, Maria Monticelli iD, Giuseppina Andreotti iD

Genes · 25.02.2024 · 15 (3) · 290

DOI: 10.3390/genes15030290 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 25.02.2024. Verfasst von Bruno Hay Mele und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Napoli "Federico II", Complesso Universitario Monte Sant'Angelo, Via Cinthia, 80126 Napoli, Italy. Hauptthemen laut MEDLINE: Drug Repositioning, Lysosomal Storage Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca, Italy, Italian Ministry of University and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rare diseases, or orphan diseases, are defined as diseases affecting a small number of people compared to the general population. Among these, we find lysosomal storage disorders (LSDs), a cluster of rare metabolic diseases characterized by enzyme mutations causing abnormal glycolipid storage. Drug repositioning involves repurposing existing approved drugs for new therapeutic applications, offering advantages in cost, time savings, and a lower risk of failure. We present a comprehensive analysis of existing drugs, their repurposing potential, and their clinical implications in the context of LSDs, highlighting the necessity of mutation-specific approaches. Our review systematically explores the landscape of drug repositioning as a means to enhance LSDs therapies. The findings advocate for the strategic repositioning of drugs, accentuating its role in expediting the discovery of effective treatments. We conclude that drug repurposing represents a viable pathway for accelerating therapeutic discovery for LSDs, emphasizing the need for the careful evaluation of drug efficacy and toxicity in disease-specific contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug RepositioningLysosomal Storage DiseasesHumansMutationLysosomes

Stichwörter der Autor:innen

drug repositioningdrug repurposinglysosomal enzyme disorderlysosomal storage diseaselysosomal storage disorder

Autor:innen und Institutionen

  • Department of Biology, University of Napoli "Federico II", Complesso Universitario Monte Sant'Angelo, Via Cinthia, 80126 Napoli, Italy.
  • Institute of Biomolecular Chemistry ICB, CNR, Via Campi Flegrei 34, 80078 Pozzuoli, Italy.
  • Stazione Zoologica "Anton Dohrn", Villa Comunale, 80121 Naples, Italy.

ORCID-Profile: Bruno Hay Mele, Maria Vittoria Cubellis, Maria Monticelli, Giuseppina Andreotti

Förderung

  • Ministero dell'Università e della Ricerca, Italy
  • Italian Ministry of University and Research

Zitieren

APA

Hay Mele, B., Rossetti, F., Cubellis, M. V., Monticelli, M., & Andreotti, G. (2024). Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat. Genes, 15(3), 290. https://doi.org/10.3390/genes15030290

Vancouver

Hay Mele B, Rossetti F, Cubellis MV, Monticelli M, Andreotti G. Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat. Genes. 2024;15(3):290. doi:10.3390/genes15030290

BibTeX
@article{HayMele2024,
  author = {Hay Mele, Bruno and Rossetti, Federica and Cubellis, Maria Vittoria and Monticelli, Maria and Andreotti, Giuseppina},
  title = {Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat},
  journal = {Genes},
  year = {2024},
  volume = {15},
  number = {3},
  pages = {290},
  doi = {10.3390/genes15030290}
}
Kostenlos starten →